retatrutide trial Eli Lilly's Next-Gen Obesity Drug Delivers Positive Weight-Loss Results ESC 2024: Retatrutide improves lipid

The Treat and Reduce Obesity Act had been introduced in Congress repeatedly since 2012, but it never gained enough traction to pass

Tirzepatide to retatrutide The tirzepatide to retatrutide transition requires extra caution because retatrutide adds glucagon receptor activation

Preliminary cardiovascular outcome data on tirzepatide in type 2 diabetes The above-mentioned preliminary cardiovascular safety data from the SURPASS-4 study demonstrated no excess cardiovascular risk associated with tirzepatide therapy (54, 73)

Lose too much muscle and your metabolism drops, your functional capacity declines, and long-term weight maintenance becomes nearly impossible

Semaglutide takes time to work

Kimberly Gudzune, the medical director for the American Board of Obesity Medicine who treats people with obesity and diabetes at Johns Hopkins, said her practice has been getting so many new requests for time-intensive prior authorizations from insurance companies that it had to hire an additional staff member to help